High blood pressure (BP) is a major public health concern, and GPs are on the front lines of managing it. We know that controlling BP is crucial for our patients’ long-term health, as it significantly reduces their risk of stroke, dementia, vision loss, and heart disease. In fact, effective BP management is arguably as vital as controlling infections or treating cancer.
But we also know that the path to optimal BP control isn’t always straightforward. A key challenge is striking the right balance: achieving adequate BP reduction without causing harm. As you know, overtreatment may be harmful, potentially compromising vital organ perfusion.
At the recent British Pharmacological Society meeting, I presented findings from a pilot study that highlights a potentially safer and more effective approach to managing hypertension, particularly in patients with more advanced disease. My research suggests that we can achieve significant BP reduction by combining multiple antihypertensive drugs at lower doses.
Combining Drugs for Safer, More Effective Dosing
Our study looked at patients with severe hypertension, identified by evidence of left ventricular hypertrophy on an ECG. We found that these patients responded well to a combination of 2 to 4 antihypertensive drugs at low doses. This approach has the potential advantages of greater tolerability and safety.
The principle is simple: by using drugs that work in different ways to lower blood pressure, we can be confident in reducing each individual drug to the least necessary dose. For example, our study found that the median daily doses of thiazides, ACE inhibitors, and beta-blockers used were much lower than their estimated effective dose 50 (ED50). This suggests that a multi-drug, low-dose strategy can be highly effective in controlling BP while minimizing the risk of side effects.
This finding supports the idea that, for patients with more advanced high blood pressure, prescribing can be both safer and more effective when drugs are carefully combined. It reminds us to consider combination therapy as a primary strategy, rather than simply increasing the dose of a single drug, to achieve our treatment goals.